Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
SEC Accession No. 0001193125-25-274336
Filing Date
2025-11-10
Accepted
2025-11-10 16:23:58
Documents
3

Document Format Files

Seq Description Document Type Size
1 S-3/A d56908ds3a.htm S-3/A 199098
2 EX-23.2 d56908dex232.htm EX-23.2 1369
3 GRAPHIC g56908g01a03.jpg GRAPHIC 35461
  Complete submission text file 0001193125-25-274336.txt   249665
Mailing Address 500 BOYLSTON STREET SUITE 1350 BOSTON MA 02116
Business Address 500 BOYLSTON STREET SUITE 1350 BOSTON MA 02116 617-655-6580
Vor Biopharma Inc. (Filer) CIK: 0001817229 (see all company filings)

EIN.: 811591163 | Fiscal Year End: 1231
Type: S-3/A | Act: 33 | File No.: 333-290490 | Film No.: 251466572
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)